These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


96 related items for PubMed ID: 16466554

  • 1. Impact of elective resection on plasma TIMP-1 levels in patients with colon cancer.
    Hammer JH, Basse L, Svendsen MN, Werther K, Brünner N, Christensen IJ, Nielson HJ.
    Colorectal Dis; 2006 Mar; 8(3):168-72. PubMed ID: 16466554
    [Abstract] [Full Text] [Related]

  • 2. Changes in plasma TIMP-1 levels after resection for primary colorectal cancer.
    Frederiksen C, Lomholt AF, Davis GJ, Dowell BL, Blankenstein MA, Christensen IJ, Brünner N, Nielsen HJ.
    Anticancer Res; 2009 Jan; 29(1):75-81. PubMed ID: 19331135
    [Abstract] [Full Text] [Related]

  • 3. Comparative studies of tissue inhibitor of metalloproteinases-1 in plasma, serum and tumour tissue extracts from patients with primary colorectal cancer.
    Sørensen NM, Schrohl AS, Jensen V, Christensen IJ, Nielsen HJ, Brünner N.
    Scand J Gastroenterol; 2008 Jan; 43(2):186-91. PubMed ID: 18224564
    [Abstract] [Full Text] [Related]

  • 4. Tissue inhibitor of metalloproteinase-1 levels in plasma from tumour arteries and veins of patients with rectal cancer.
    Frederiksen C, Lykke J, Christensen IJ, Brünner N, Nielsen HJ.
    Scand J Clin Lab Invest; 2007 Jan; 67(5):545-52. PubMed ID: 17763191
    [Abstract] [Full Text] [Related]

  • 5. High preoperative plasma tissue inhibitor of metalloproteinase-1 levels are associated with short survival of patients with colorectal cancer.
    Holten-Andersen MN, Stephens RW, Nielsen HJ, Murphy G, Christensen IJ, Stetler-Stevenson W, Brünner N.
    Clin Cancer Res; 2000 Nov; 6(11):4292-9. PubMed ID: 11106246
    [Abstract] [Full Text] [Related]

  • 6. Elevated plasma tissue inhibitor of metalloproteinase-1 level predicts decreased response and survival in metastatic breast cancer.
    Lipton A, Ali SM, Leitzel K, Demers L, Evans DB, Hamer P, Brown-Shimer S, Pierce K, Carney W.
    Cancer; 2007 May 15; 109(10):1933-9. PubMed ID: 17407159
    [Abstract] [Full Text] [Related]

  • 7. Total levels of tissue inhibitor of metalloproteinases 1 in plasma yield high diagnostic sensitivity and specificity in patients with colon cancer.
    Holten-Andersen MN, Christensen IJ, Nielsen HJ, Stephens RW, Jensen V, Nielsen OH, Sørensen S, Overgaard J, Lilja H, Harris A, Murphy G, Brünner N.
    Clin Cancer Res; 2002 Jan 15; 8(1):156-64. PubMed ID: 11801553
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Influence of open versus laparoscopically assisted colectomy on soluble vascular endothelial growth factor (sVEGF) and its soluble receptor 1 (sVEGFR1).
    Svendsen MN, Werther K, Christensen IJ, Basse L, Nielsen HJ.
    Inflamm Res; 2005 Nov 15; 54(11):458-63. PubMed ID: 16307219
    [Abstract] [Full Text] [Related]

  • 12. Impact of plasma tissue inhibitor of matrix metalloproteinase-1 on long-term survival in patients with colorectal cancer.
    Yukawa N, Yoshikawa T, Akaike M, Sugimasa Y, Rino Y, Masuda M, Imada T.
    Oncology; 2007 Nov 15; 72(3-4):205-8. PubMed ID: 18160809
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Plasma TIMP-1 in patients with colorectal adenomas: a prospective study.
    Holten-Andersen MN, Fenger C, Nielsen HJ, Rasmussen AS, Christensen IJ, Brünner N, Kronborg O.
    Eur J Cancer; 2004 Sep 15; 40(14):2159-64. PubMed ID: 15341992
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Serum TIMP-1 in gastric cancer patients: a potential prognostic biomarker.
    Wang CS, Wu TL, Tsao KC, Sun CF.
    Ann Clin Lab Sci; 2006 Sep 15; 36(1):23-30. PubMed ID: 16501233
    [Abstract] [Full Text] [Related]

  • 17. Tissue inhibitor of metalloproteinases-1 in the postoperative monitoring of colorectal cancer.
    Holten-Andersen MN, Nielsen HJ, Sørensen S, Jensen V, Brünner N, Christensen IJ.
    Eur J Cancer; 2006 Aug 15; 42(12):1889-96. PubMed ID: 16809030
    [Abstract] [Full Text] [Related]

  • 18. Circulating gelatinases and tissue inhibitor of metalloproteinase-1 in colorectal cancer metastatic liver disease.
    Waas ET, Wobbes T, Ruers T, Lomme RM, Hendriks T.
    Eur J Surg Oncol; 2006 Sep 15; 32(7):756-63. PubMed ID: 16650961
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Effects of preoperative carbohydrate loading on the changes in serum tumor necrosis factor receptors 1 and 2 and insulin resistance in patients of colon carcinoma].
    An GQ, Zhao XL, Gao YC, Wang GY, Yu YM.
    Zhonghua Yi Xue Za Zhi; 2008 Jul 29; 88(29):2041-4. PubMed ID: 19080431
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.